News
Better Bull Market Buy: Pfizer vs. Moderna
COVID-19 has been especially rough for Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) investors over the last couple of years. Shares of both drugmakers have plunged as the demand for their
Why Humana Stock Fell Today
Shares of Humana (NYSE: HUM) fell as much as 12.8% on Thursday after the health insurance company cut its 2023 guidance, citing rising Medicare Advantage costs amid "higher than anticipated
2 Beaten-Down Stocks to Buy Hand Over Fist This Year
While the market bounced back last year, some stocks failed to keep pace with broader equities. That was the case with pharma giant AbbVie (NYSE: ABBV) and e-commerce specialist Etsy (NASDAQ: ETSY)
EQS-News: Biotest AG opens 11th plasma collection centre in Germany
Better Telecom Stock: Lumen Technologies vs. AT&T
Lumen Technologies (NYSE: LUMN) and AT&T (NYSE: T) are two of the largest telecom companies in the United States. Lumen, formerly known as CenturyLink, is one of the country's largest wireline
The Best Stock to Invest $1,000 in Right Now
It's hard for me to pick my top favorite in many categories. Whether talking about actors, athletes, songs, singers, movies, or TV shows, I find it difficult to single one out as the best.
This
Why Alibaba Stock Was Falling Again Today
Shares of Alibaba Group (NYSE: BABA) were sliding again today as further signs of weakness emerged in the Chinese economy.
In an effort to restore optimism about China's recovery, the country
Valbiotis sets out its commercial and clinical roadmap for 2024
4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond
In this video, I will go over four healthcare stocks that represent different exposures to the healthcare industry. One of the companies I cover happens to be the fifth-largest player in the
Tilray Brands Just Posted Record Revenue, but Here's Why Investors Aren't Impressed
Top Canadian cannabis producer Tilray Brands (NASDAQ: TLRY) recently reported earnings. But despite the record sales numbers, the stock hasn't been soaring in value. Instead, it has been falling in
Better Growth Stock: Abbott vs. AbbVie
Abbott Laboratories (NYSE: ABT) and AbbVie (NYSE: ABBV) share a common past. About a decade ago, Abbott spun out its pharmaceuticals business into a separate company to create AbbVie. Since then
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024
I'm Passing on Pfizer Stock in 2024. Here's Why.
One of the most important companies during the peak of the COVID-19 pandemic was pharmaceutical giant Pfizer (NYSE: PFE). The company's breakthrough vaccine helped pave the way for a post-pandemic
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
For all of its many successes, the healthcare industry isn't exactly a hotbed of dividend-paying stocks. However, this doesn't mean the sector is entirely without companies that remunerate their
Down 88%, Could Editas Medicine Be a Good Investment Now?
It's been a few years since the average investor behaved as if no challenge was too tough for America's biopharmaceutical industry. In turn, shares of gene-editing startup Editas Medicine (NASDAQ:
Is Pfizer Stock a Buy in 2024?
If you're in the process of rebalancing your portfolio, you might be considering buying Pfizer (NYSE: PFE) stock. After all, the drugmaker pays a sizzling 5.92% dividend yield, its shares trade at
7 Incredible Reasons to Buy Pfizer Stock Right Now
Last year, pharmaceutical giant Pfizer (NYSE: PFE) encountered several issues, none more significant than the massive drop in revenue and earnings it experienced due to a shrinking coronavirus
3 Unstoppable Stocks to Buy in 2024
There's no guarantee that any stock is completely unstoppable. However, three Motley Fool contributors think they've identified some that come close. Here's why they picked Eli Lilly (NYSE: LLY)
2 Red Flags That Could Sink Pfizer in 2024
Last year wasn't a particularly good one for Pfizer (NYSE: PFE). Even CEO Albert Bourla says so. "We missed our internal projections and also, we missed the expectations of The Street... And
Why Vera Therapeutics Stock Soared by 22% This Week
Clinical-stage biotech Vera Therapeutics (NASDAQ: VERA) had a week to remember on the stock market. Over the past five trading days, according to data compiled by S&P Global Market Intelligence, the
Why UnitedHealth Stock Flopped on Friday
While investors love when one of their companies beats analyst estimates, it's not always the case that its stock rises in reaction. That was the case Friday with big health insurance company
UnitedHealth Group (UNH) Q4 2023 Earnings Call Transcript
UnitedHealth Group (NYSE: UNH)Q4 2023 Earnings CallJan 12, 2024, 8:45 a.m. ET
Operator
Source Fool.com
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
A Bull Market Is Coming: 2 Magnificent Stocks Down More Than 50% to Buy Right Now
After a tough 2022 and gains in 2023, it's fair to say the stock market is probably on the way to better days. In any case, history tells us that bear markets, such as the one that began in 2022
Why Amarin Stock Skyrocketed Today
Shares of Amarin (NASDAQ: AMRN) skyrocketed 32.9% on Wednesday after the biopharmaceutical company announced strong preliminary fiscal fourth-quarter results, a new share-repurchase authorization